Literature DB >> 27268516

Prevalence and Predictors of Metabolic Syndrome in People With Schizophrenia in Inpatient Rehabilitation Wards.

Chiu-Yueh Yang1, Su-Chen Lo2, Ying-Chieh Peng2.   

Abstract

BACKGROUND: Atypical antipsychotic medications increase the risk of developing metabolic syndrome (MetS) and cardiovascular diseases in people with schizophrenia. AIM: To explore the prevalence of MetS and the predictors associated with the number of MetS components in people with chronic schizophrenia.
METHODS: We recruited 357 participants from 10 rehabilitation wards in northern Taiwan. The Beck Anxiety Inventory, Beck Depression Inventory-II, Health-Promoting Lifestyle Profile (HPLP), and modified Baecke physical activity questionnaire were used to evaluate the participants. MetS prevalence was calculated using the modified Adult Treatment Panel III criteria for Asians.
RESULTS: The prevalence of MetS in this sample was 37.8%. Multinomial logistic regression revealed that the HPLP-exercise score (odds ratio [OR] = 0.411, p = .002) and depressive symptoms (OR = 0.949, p = .040) were protective factors for ≥4 MetS components. The leisure physical activity level (OR = .536, p = .024) was a protective factor for three MetS components. Body mass index ≥24 kg/m(2) was the strongest risk factor for two MetS components (OR = 8.057, p < .001), three MetS components (OR = 11.287, p < .001), and ≥four MetS components (OR = 15.621, p < .001). Additionally, participants' age >40 (OR = 3.638, p = .012) was a risk factor for ≥four MetS components.
CONCLUSION: In this study, the prevalence of MetS was higher than that reported for patients utilizing community-based services in Taiwan. The important risk factors for MetS were being overweight and older than 40. The protective factors for MetS were a high HPLP-exercise score and leisure-based physical activities.
© The Author(s) 2016.

Entities:  

Keywords:  metabolic syndrome; predictors; prevalence; schizophrenia

Mesh:

Substances:

Year:  2016        PMID: 27268516     DOI: 10.1177/1099800416653184

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  4 in total

1.  Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review.

Authors:  Marius H Sneller; Nini de Boer; Sophie Everaars; Max Schuurmans; Sinan Guloksuz; Wiepke Cahn; Jurjen J Luykx
Journal:  Front Psychiatry       Date:  2021-03-29       Impact factor: 4.157

2.  Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals.

Authors:  Elena G Kornetova; Alexander N Kornetov; Irina A Mednova; Anastasia A Goncharova; Valeria I Gerasimova; Ivan V Pozhidaev; Anastasiia S Boiko; Arkadiy V Semke; Anton J M Loonen; Nikolay A Bokhan; Svetlana A Ivanova
Journal:  Front Psychiatry       Date:  2021-07-02       Impact factor: 4.157

3.  Risk Factors of Metabolic Syndrome in Community-Dwelling People with Schizophrenia.

Authors:  Min Jung Sun; Mi Heui Jang
Journal:  Int J Environ Res Public Health       Date:  2020-09-14       Impact factor: 3.390

4.  Metabolic Syndrome and Dietary Habits in Hospitalized Patients with Schizophrenia: A Cross-Sectional Study.

Authors:  Tamara Sorić; Mladen Mavar; Ivana Rumbak
Journal:  Medicina (Kaunas)       Date:  2021-03-10       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.